Human DNMT1/DNMT3B Double Knockout Cell Line-HEK293T

The Human DNMT1/DNMT3B Double Knockout Cell Line - HEK293T is a powerful tool for a variety of research applications in the fields of epigenetics, cancer biology, and gene regulation. Here are some of the key applications:

Epigenetic Research: By eliminating DNMT1 and DNMT3B, researchers can effectively study the effects of disrupted methylation patterns on gene expression, revealing epigenetic regulation of various biological processes.

Cancer Research: Given the role of DNA methylation in cancer, this knockout cell line is valuable for studying the mechanisms by which aberrant methylation leads to carcinogenesis. It helps identify potential biomarkers and therapeutic targets that are unique to epigenetic modifications in cancer cells.

Gene Expression Analysis: Researchers can use high-throughput sequencing and other gene expression analyses to understand the broad effects of DNMT knockout on cellular function, providing insights into gene regulatory networks.

Drug Screening and Development: This cell line is an important model for screening drugs that target DNA methylation pathways. It enables pharmaceutical researchers to identify and evaluate compounds that can modulate methylation, providing potential treatments for diseases associated with epigenetic dysregulation.

Development of Epigenetic Therapies: Using this cell line, researchers can test the efficacy and specificity of new epigenetic therapies. This is particularly important for developing treatments for cancer and other diseases where DNA methylation patterns are disrupted.